Your browser doesn't support javascript.
loading
Severe Posaconazole-Induced Glucocorticoid Deficiency with Concurrent Pseudohyperaldosteronism: An Unfortunate Two-for-One Special.
Villar-Prados, Alejandro; Chang, Julia J; Stevens, David A; Schoolnik, Gary K; Wang, Samantha X Y.
Afiliação
  • Villar-Prados A; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Chang JJ; Division of Endocrinology, Metabolism, and Gerontology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Stevens DA; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Schoolnik GK; California Institute of Medical Research, San Jose, CA 95128, USA.
  • Wang SXY; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
J Fungi (Basel) ; 7(8)2021 Jul 30.
Article em En | MEDLINE | ID: mdl-34436160
ABSTRACT
A 56-year-old Hispanic man with a history of disseminated coccidioidomycosis was diagnosed with persistent glucocorticoid insufficiency and pseudohyperaldosteronism secondary to posaconazole toxicity. This case was notable for unexpected laboratory findings of both pseudohyperaldosteronism and severe glucocorticoid deficiency due to posaconazole's mechanism of action on the adrenal steroid synthesis pathway. Transitioning to fluconazole and starting hydrocortisone resolved the hypokalemia but not his glucocorticoid deficiency. This case highlights the importance of recognizing iatrogenic glucocorticoid deficiency with azole antifungal agents and potential long term sequalae.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article